Cargando…

Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial

BACKGROUND: Exercise during chemotherapy is a promising strategy to reduce fatigue and improve health-related quality of life (HRQoL). It has been shown to be feasible and efficient in various cancers, including advanced-stage cancers. Effects of physical activity have never been explored in advance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuzillet, Cindy, Vergnault, Mathieu, Bonnetain, Franck, Hammel, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603729/ https://www.ncbi.nlm.nih.gov/pubmed/26458923 http://dx.doi.org/10.1186/s13063-015-0983-8

Ejemplares similares

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial
por: Bachet, Jean-Baptiste, et al.
Publicado: (2015)

Diabetische voetzorg is multidisciplinair teamwerk
por: Ekelmans, Nathalie
Publicado: (2021)

Oncologie
por: Marcelloni, Claudia
Publicado: (2022)

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
por: Charton, Emilie, et al.
Publicado: (2019)

Prise en charge multidisciplinaire des pneumopathies nécrosantes ventilées
por: Rabbat, A., et al.
Publicado: (2013)

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2016)

Oncologie et COVID-19
Publicado: (2020)

Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study
por: Diouf, Momar, et al.
Publicado: (2014)

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2015)

L’oncologie médicale, nouvelle spécialité en Afrique?
por: Brahmi, Sami Aziz, et al.
Publicado: (2017)

Nouveaux concepts de consultations médicales en oncologie
por: Bibault, J.-E., et al.
Publicado: (2020)

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study
por: Chibaudel, Benoist, et al.
Publicado: (2015)

Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial
por: Soubeyran, Pierre, et al.
Publicado: (2016)

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis
por: de Mestier, Louis, et al.
Publicado: (2012)

Prise en charge multidisciplinaire des abcès amibiens du foie au CHU de Yopougon, Abidjan-Côte d'Ivoire
por: Kouamé, N'goran, et al.
Publicado: (2010)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
por: Turpin, Anthony, et al.
Publicado: (2022)

Neutropénie fébrile chimio-induite dans une unité d’oncologie pédiatrique tunisienne
por: Fedhila, Faten, et al.
Publicado: (2022)

Se former à l’oncologie en période de pandémie de COVID-19
por: Delaye, Matthieu, et al.
Publicado: (2021)

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists
por: Methy, Nicolas, et al.
Publicado: (2010)

Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study
por: Jary, Marine, et al.
Publicado: (2022)

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors
por: Hammel, Pascal, et al.
Publicado: (2020)

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
por: Kim, Stefano, et al.
Publicado: (2017)

Plasmocytome solitaire osseux: expérience de l'institut national d'oncologie de Rabat (INO)
por: Diakité, Adama, et al.
Publicado: (2014)

Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)
por: Servagi-Vernat, Stéphanie, et al.
Publicado: (2017)

Rationale of the PAPAartis trial
por: Misfeld, Martin, et al.
Publicado: (2023)

Aspects cliniques des cancers bronchopulmonaires primitifs au service d'oncologie du CHUA-HUJRA Antananarivo
por: Refeno, Valéry, et al.
Publicado: (2015)

Les traitements du cancer de la vulve: expérience du Centre d’Oncologie d’Oujda
por: Dahbi, Zineb, et al.
Publicado: (2018)

Épidémie de COVID-19 : recommandations à l’usage des professionnels de l’oncologie radiothérapie
por: Giraud, P., et al.
Publicado: (2020)

SARS-CoV-2 et cancer en France : les internes d’oncologie en première ligne. Témoignage des internes d’oncologie de deux clusters français : le Grand-Est et l’Île-de-France
por: Delaye, Matthieu, et al.
Publicado: (2020)

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Les perdus de vue en radiothérapie: expérience de l'Institut National d'Oncologie au Maroc
por: Mezouri, Imane, et al.
Publicado: (2014)

La problématique du coût des nouvelles thérapeutiques en oncologie: qu'en-est-il du Maroc?
por: Brahmi, Sami Aziz, et al.
Publicado: (2016)

Colloque de l'Association des Professeurs de l'Université de Genève: Les critères de vérité dans la recherche scientifique, un dialogue multidisciplinaire
por: Buscaglia, M, et al.
Publicado: (1983)

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
por: Hilmi, Marc, et al.
Publicado: (2018)

Health-related quality of life as an endpoint in oncology phase I trials: a systematic review
por: Fiteni, Frédéric, et al.
Publicado: (2019)

Parenteral nutrition at the palliative phase of advanced cancer: the ALIM-K study protocol for a randomized controlled trial
por: Pazart, Lionel, et al.
Publicado: (2014)

The Alliance AMBUSH Trial: Rationale and Design
por: Mahajan, Anita, et al.
Publicado: (2022)

Cancer pulmonaire: parcours de soins au service de radiothérapie à l'institut national d'oncologie de Rabat
por: Lachgar, Amine, et al.
Publicado: (2015)

Méditation et relation de soin dans une unité d’oncologie thoracique à l’ère du Covid-19
por: Messekher, M., et al.
Publicado: (2023)

Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database
por: Hirt, Julian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2k5q0p9pck36m7hr5rk65c2jcc